AKA-23336-03948 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2023-01-06
Dose 1 — Pfizer-BioNTech
2023-02-06
Dose 2 — Pfizer-BioNTech
2023-02-15
Registered in v-safe
2023-02-15
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2023-02-20
Survey response — day 14, dose 2, under 3
MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11
2023-02-27
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-03-06
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-03-13
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-03-22
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-05-08
Health check-in — 3 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2023-01-06	Pfizer-BioNTech	No
2	2023-02-06	Pfizer-BioNTech	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release